Company intelligence / Profile preview
ApicHope Pharmaceutical Group
- Ownership
- Private
- Employees
- ~1676
- Development stage
- Phase 2
Overview
ApicHope Pharmaceutical Group is a leading Chinese pharmaceutical company with a broad portfolio of approved drugs focused on pediatric medicines, antivirals, antibiotics, and chronic disease therapies. The company has over 48 clinical trials registered and several products approved in China since 2002. Its pipeline includes both innovative small molecules and vaccines[1][2][3].
- Therapeutic areas
- PulmonologyCardiovascularInfectious Diseases
- Modalities
- Small moleculeProphylactic vaccineVirus-like particle vaccineChemical drugDegradable molecular glue
- Industry
- Biotech
Drug pipeline
18 assets17 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on ApicHope Pharmaceutical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ApicHope Pharmaceutical Group.